Success Metrics

Active Trials

2(50%)

Phase Distribution

Ph phase_4

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Other(1)

Detailed Status

Recruiting2

Not yet recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 4

Trials by Phase

Phase 21 (25.0%)

Phase 43 (75.0%)

Trials by Status

recruiting250%

not_yet_recruiting125%

unknown125%

Recent Activity

2 active trials

Showing 4 of 4

recruitingphase_4

Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial

NCT07338773

not_yet_recruitingphase_2

IO Vancomycin Spine

NCT06748144

recruitingphase_4

Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty

NCT06384651

unknownphase_4

IO vs IV Vancomycin in Tourniquetless TKA

NCT05705843

Clinical Trials (4)

Showing 4 of 4 trials

NCT07338773Phase 4

Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial

IO Vancomycin Spine

Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty

Recruiting

NCT05705843Phase 4

IO vs IV Vancomycin in Tourniquetless TKA

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4